Molecular features of ascitic ovarian cancer cells detected by immunofluorescence assay using flow cytometry


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Peritoneal dissemination and growth of tumor cells in the ascitic fluid in stages III and IV of recurrent ovarian cancer is difficult to treat; resistance to many anticancer drugs used in the treatment of solid ovarian cancer is observed at this stage. The author’s hypothesis that the differences in the molecular phenotype of tumor cells for various types of the disease could be an explanation for this. A comparative evaluation of the expression and coexpression of a number of molecular markers (immunofluorescence assay with flow cytometry) was performed using solid and ascitic ovarian cancer cells. In contrast to solid ovarian cancer, ascitic ovarian cancer cells present leukocyte common antigen CD45 and mesenchymal marker vimentin in addition to epithelial marker cytokeratin. In addition to the inhibition of anoikis (specific mechanism of epithelial cell death in a liquid medium in the absence of contact with the substrate), ascitic ovarian cancer cells are characterized by (1) emperipolesis (intracellular migration of leukocytes without damage to the tumor cell), and (2) phenotype of epithelial-mesenchymal transition. Thus, the data on clinically significant molecular differences between solid and recurrent ascitic ovarian cancer was first obtained, opening up opportunities for anticancer therapy, which previously was not used in the treatment of ovarian cancer.

作者简介

T. Bogush

Blokhin Russian Cancer Research Center

编辑信件的主要联系方式.
Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

S. Kaliuzhny

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

E. Dudko

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

V. Kirsanov

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

A. Tjulandina

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

E. Bogush

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

S. Tjulandin

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

M. Davydov

Blokhin Russian Cancer Research Center

Email: labmedchem@mail.ru
俄罗斯联邦, Moscow

补充文件

附件文件
动作
1. JATS XML

版权所有 © Allerton Press, Inc., 2016